Jf. Collins et al., POTENCY EQUIVALENCY FACTORS FOR SOME POLYCYCLIC AROMATIC-HYDROCARBONSAND POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVES, Regulatory toxicology and pharmacology, 28(1), 1998, pp. 45-54
Potency equivalency factors (PEFs) for cancer induction relative to be
nzo[a]pyrene have been derived for 21 polycyclic aromatic hydrocarbons
(PAHs) and PAH derivatives based on a data preference scheme. PEFs ha
ve been derived only for PAHs with demonstrated carcinogenicity in bio
assays. Cancer potency values and inhalation unit risks are presented
for four additional carcinogenic PAHs based on expedited risk assessme
nts conducted for California's Proposition 65. A much larger number of
PAHs and PAH derivatives are considered mutagenic or genotoxic and ma
y have limited evidence for carcinogenicity, but these compounds are n
ot considered in this evaluation. New cancer bioassay data and possibl
y structure-activity analysis may indicate that additional PAHs are ca
rcinogenic. Thus, additional PAHs may be identified as potential human
carcinogens when such data become available. However, until that time
the PEFs proposed for use in risk assessment were estimated only for
PAHs currently classified as carcinogens.